Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma

There are unmet medical needs for patients with lung squamous cell carcinoma (LSCC). Therefore, in this study, we explored the antitumor potential of third-generation glypican 3 (GPC3)-redirected chimeric antigen receptor (CAR)-engineered T lymphocytes (CARgpc3 T cells) in tumor models of LSCC. Firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kesang, Pan, Xiaorong, Bi, Yanyu, Xu, Wen, Chen, Cheng, Gao, Huiping, Shi, Bizhi, Jiang, Hua, Yang, Shengli, Jiang, Liyan, Li, Zonghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823050/
https://www.ncbi.nlm.nih.gov/pubmed/26684028
http://dx.doi.org/10.18632/oncotarget.6595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823050/
https://www.ncbi.nlm.nih.gov/pubmed/26684028
http://dx.doi.org/10.18632/oncotarget.6595

Ejemplares similares